Mandate

Vinge advised Goldman Sachs and Nordea in relation to Thule’s listing on Nasdaq Stockholm

December 09, 2014

Vinge advised Goldman Sachs International and Nordea Bank AB (publ) – joint global coordinators and joint bookrunners – in relation to Thule Group AB’s application for listing on Nasdaq Stockholm. Thule’s principal shareholder is Nordic Capital. A prospectus was published on 13 November and the first day of trading on Nasdaq Stockholm was on 26 November. The total value of the offering amounts to SEK 2.1 billion, assuming that the over-allotment option is exercised in full.

Thule Group is a premium branded sports and outdoor company, with global leadership in the sport and cargo carriers market (e.g. bike carriers and roof racks) and is a leading company within other outdoor and bags product markets, selling its products in 136 countries, primarily through the Thule and Case Logic brands. The Company’s largest brand, Thule, is a premium brand recognized throughout the world among active consumers for products that are safe, easy-to-use and have a contemporary design. Through its Case Logic brand, the Company is well-established in many geographic locations in the bags for electronic devices market.

Vinge’s team consisted mainly of Peter Bäärnhielm, David Andersson and Sabina Börjesson.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025